Quality by Design in Clinical Trials: A Collaborative Pilot With FDA.

Area of Science:

• Clinical Trials
• Pharmaceutical Development
• Regulatory Science

Background:

• Clinical trial quality is crucial for reliable results and patient safety.
• Assessing quality involves meeting stakeholder needs and minimizing errors.
• Quality planning must occur during trial design and before conduct.

Purpose of the Study:

• To describe a pharmaceutical sponsor's quality planning process for a clinical trial.
• To report on the U.S. Food and Drug Administration's (FDA) pilot review of an integrated quality management plan.
• To demonstrate the utility of this process for aligning sponsors and regulators on trial quality.

Main Methods:

• A pharmaceutical sponsor developed an integrated quality management plan.
• The U.S. Food and Drug Administration (FDA) conducted a pilot review of this plan.
• The process involved prospective quality goal establishment and development of necessary processes.

Main Results:

• The pilot review confirmed the usefulness of the quality planning process.
• The process facilitated alignment between the sponsor and the FDA regarding clinical trial quality.
• Key deficiencies and errors in clinical trials can be proactively addressed.

Conclusions:

• Integrated quality management planning is essential for high-quality clinical trials.
• Sponsor-regulator collaboration on quality planning improves trial oversight.
• This systematic approach enhances the reliability and integrity of clinical trial data.